Perrigo Stock Forecast, Price & News

Perrigo (NYSE:PRGO) Frequently Asked Questions

Is Perrigo a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Perrigo stock.
View analyst ratings for Perrigo or view top-rated stocks.

How has Perrigo's stock been impacted by COVID-19?

Perrigo's stock was trading at $46.04 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PRGO shares have decreased by 12.1% and is now trading at $40.46.
View which stocks have been most impacted by COVID-19.

Are investors shorting Perrigo?

Perrigo saw a increase in short interest during the month of December. As of December 15th, there was short interest totaling 6,900,000 shares, an increase of 24.8% from the November 30th total of 5,530,000 shares. Based on an average daily trading volume, of 1,570,000 shares, the days-to-cover ratio is currently 4.4 days. Approximately 5.2% of the company's stock are short sold.
View Perrigo's Short Interest.

When is Perrigo's next earnings date?

Perrigo is scheduled to release its next quarterly earnings announcement on Monday, March 7th 2022.
View our earnings forecast for Perrigo.

How were Perrigo's earnings last quarter?

Perrigo Company plc (NYSE:PRGO) released its quarterly earnings results on Wednesday, November, 10th. The company reported $0.45 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.65 by $0.20. The firm had revenue of $1.04 billion for the quarter, compared to analysts' expectations of $1.05 billion. Perrigo had a negative net margin of 5.86% and a positive trailing twelve-month return on equity of 5.88%. During the same period in the previous year, the company posted $0.93 EPS.
View Perrigo's earnings history.

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo declared a quarterly dividend on Tuesday, November 2nd. Investors of record on Friday, December 3rd will be paid a dividend of $0.24 per share on Tuesday, December 21st. This represents a $0.96 annualized dividend and a yield of 2.37%. The ex-dividend date of this dividend is Thursday, December 2nd.
View Perrigo's dividend history.

Is Perrigo a good dividend stock?

Perrigo pays an annual dividend of $0.96 per share and currently has a dividend yield of 2.43%.
View Perrigo's dividend history.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo updated its FY 2021 earnings guidance on Wednesday, December, 8th. The company provided EPS guidance of $2.000-$2.100 for the period, compared to the Thomson Reuters consensus estimate of $2.460. The company issued revenue guidance of -.

What price target have analysts set for PRGO?

4 brokerages have issued 12 month target prices for Perrigo's stock. Their forecasts range from $45.00 to $63.00. On average, they expect Perrigo's stock price to reach $52.75 in the next year. This suggests a possible upside of 30.4% from the stock's current price.
View analysts' price targets for Perrigo or view top-rated stocks among Wall Street analysts.

Who are Perrigo's key executives?

Perrigo's management team includes the following people:

• Murray S. Kessler, President, Chief Executive Officer & Director
• Raymond P. Silcock, CFO, Principal Accounting Officer & Executive VP (LinkedIn Profile)
• Thomas M. Farrington, Chief Information Officer & Executive VP
• Grainne Quinn, Chief Medical Officer & Executive Vice President
• Todd W. Kingma, Secretary, Executive VP & General Counsel (LinkedIn Profile)

What is Murray S. Kessler's approval rating as Perrigo's CEO?

38 employees have rated Perrigo CEO Murray S. Kessler on Glassdoor.com. Murray S. Kessler has an approval rating of 83% among Perrigo's employees.

Who are some of Perrigo's key competitors?

Some companies that are related to Perrigo include Johnson & Johnson (JNJ), Pfizer (PFE), AbbVie (ABBV), Eli Lilly and (LLY), Merck & Co., Inc. (MRK), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), Horizon Therapeutics Public (HZNP), Jazz Pharmaceuticals (JAZZ), Pacira BioSciences (PCRX), Nektar Therapeutics (NKTR), Corcept Therapeutics (CORT), Supernus Pharmaceuticals (SUPN) and Zogenix (ZGNX).
View all of PRGO's competitors.

What other stocks do shareholders of Perrigo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Allergan (AGN), Intel (INTC), Johnson & Johnson (JNJ), Netflix (NFLX), QUALCOMM (QCOM) and Amgen (AMGN).

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Who are Perrigo's major shareholders?

Perrigo's stock is owned by a variety of institutional and retail investors. Top institutional investors include Coho Partners Ltd. (1.94%), Pendal Group Ltd (0.42%), Louisiana State Employees Retirement System (0.03%), Cutler Group LP (0.00%), State of Alaska Department of Revenue (0.01%) and Exchange Traded Concepts LLC (0.01%). Company insiders that own Perrigo stock include Bradley A Alford, Geoffrey M Parker, Raymond Silcock, Richard S Sorota, Rolf A Classon, Svend Andersen, Theodore R Samuels II and Todd W Kingma.
View institutional ownership trends for Perrigo.

Which institutional investors are selling Perrigo stock?

PRGO stock was sold by a variety of institutional investors in the last quarter, including Coho Partners Ltd., Cutler Group LP, State of Alaska Department of Revenue, and Crossmark Global Holdings Inc..
View insider buying and selling activity for Perrigo or view top insider-selling stocks.

Which institutional investors are buying Perrigo stock?

PRGO stock was bought by a variety of institutional investors in the last quarter, including Pendal Group Ltd, Exchange Traded Concepts LLC, NuWave Investment Management LLC, Spire Wealth Management, Ridgewood Investments LLC, and Louisiana State Employees Retirement System. Company insiders that have bought Perrigo stock in the last two years include Bradley A Alford, Geoffrey M Parker, Raymond Silcock, Richard S Sorota, Rolf A Classon, Svend Andersen, Theodore R Samuels II, and Todd W Kingma.
View insider buying and selling activity for Perrigo or or view top insider-buying stocks.

How do I buy shares of Perrigo?

Shares of PRGO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $40.46.

How much money does Perrigo make?

Perrigo has a market capitalization of $5.41 billion and generates $5.06 billion in revenue each year. The company earns $-162.60 million in net income (profit) each year or ($1.88) on an earnings per share basis.

How many employees does Perrigo have?

Perrigo employs 11,500 workers across the globe.

When was Perrigo founded?

Perrigo was founded in 1887.

What is Perrigo's official website?

The official website for Perrigo is www.perrigo.com.

Where are Perrigo's headquarters?

Perrigo is headquartered at THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010.

How can I contact Perrigo?

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The company can be reached via phone at (531) 709-4000, via email at [email protected], or via fax at 269-673-9128.